Details

Industries

Biotechnology,Health Care,Hospital,Therapeutics

Founded date

Jan 1, 2000

Number Of Employee

11 - 50

Operating Status

Active

Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and MYDICAR, an enzyme replacement therapy for heart failure. Celladon was founded in 2000 and is based in La Jolla, California.